We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guests today are Jamie Luu, RDN, LDN, Strategy and Nutrition Manager, and Ronja Krieger, Chief Nutritionist at Almased. The Almased-type diet can boost natural satiety signals via GLP-1 and PYY — that is real and meaningful. But the new GLP-1-RA drugs go much further: they hijack those same signals, ramp them much higher, and translate into large weight losses in patients with obesity. So the diet is a “natural nudging” of the system; the drugs are a strong “override” of the system.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

• You’re showing that the Almased high-protein diet raised GLP-1 and PYY levels — how would you compare that to what we know about the injectable GLP-1 drugs (like Ozempic)? Is the mechanism the same, just a different scale, or is there something qualitatively different going on?
• I read the IIS paper from 2021 and the results are impressive. Given that the diet intervention was isocaloric (same calories) and short-term, yet still changed appetite-hormone profiles — is Almased complementary to GLP-1 drugs like Ozempics or a preventive/maintenance tool for people who aren’t yet eligible for—or don’t want—drugs?
• For someone who isn’t on GLP-1 medication, what are realistic expectations of using a high-protein total diet replacement in terms of appetite regulation, hormone effects, and perhaps weight maintenance? And how should they view that in the context of the new drug therapies that dominate headlines?

Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.

Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

• Apple Podcasts
• Spotify
• iHeartRadio
• Amazon Music
• Pandora
• YouTube

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Denali Rose, VP at Veeva, and Co-Host of Note to File. Rose’s parents are outdoors people and named her after the national park in Alaska. Personally, this is one of the most fun shows we’ve ever done. ‘Nuff said – get in and listen! She is Vice President Sales & Strategy, Site Solutions at Veeva. That’s her day job – she’s also the Co-Host and Producer of the Note To File podcast. She’s focused on delivering solutions for clinical research sites, guiding the sales cycle, and aligning strategy to drive impact and growth. She’s super smart and extremely experienced in the patterns and anti-patterns in the clinical trial industry.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

• Tell me about your journey.
• How did you get into podcasting, and why do you think it’s important?
• CROs are part of the problem, and therefore, they cannot be a part of the solution; sites will inherit the Earth – what is your take on this? Do you think CROs are part of the problem and therefore can’t be part of the solution? Do you think sites will actually inherit the Earth?
• What other hats do you wear besides ClinOps?

Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.

Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

• Apple Podcasts
• Spotify
• iHeartRadio
• Amazon Music
• Pandora
• YouTube

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!